Literature DB >> 23426813

Frequency of subclinical hypothyroidism in 5- to 15-year-old children with migraine headache.

Razieh Fallah1, Mehrdad Mirouliaei, Nasrollah Bashardoost, Mina Partovee.   

Abstract

BACKGROUND: Migraine is the most frequent acute recurrent primary headache in childhood. Hypothyroidism may be an exacerbating factor for some primary headaches. The purpose of this study was to determine the frequency of subclinical hypothyroidism in children with migraine headache.
METHODS: In a cross-sectional analytic study, the thyroid function tests of 5- to 15-year-old migraineurs who were referred to the Pediatric Neurology Clinic of Shahid Sadoughi University of Medical Sciences from January 2010 to February 2011 in Yazd, Iran, were measured based on the second edition of the International Classification of Headache Disorders.
RESULTS: Forty-eight girls (46.2%) and 56 boys (53.8%) with mean age of 10.46±2.72 years were evaluated. Twenty-five (24%) children had hypothyroidism. The monthly frequency of headache (mean±SD, 14.75±8.9 vs. 20.12±9.49, p=0.04) and the duration of headache (mean±SD, 1.96±1.08 vs. 3.75±2.71 h, p=0.03) were more statistically significant in migraineur children with hypothyroidism, but the mean age, mean of onset age of migraine, sex distribution, and severity of headache were not statistically different in both groups.
CONCLUSION: Based on the results of this study, subclinical hypothyroidism was as an exacerbating factor for migraine headache. Therefore, it is logical to check the thyroid function tests in migraineur children.

Entities:  

Mesh:

Year:  2012        PMID: 23426813     DOI: 10.1515/jpem-2012-0121

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Common variants at 5q33.1 predispose to migraine in African-American children.

Authors:  Xiao Chang; Renata Pellegrino; James Garifallou; Michael March; James Snyder; Frank Mentch; Jin Li; Cuiping Hou; Yichuan Liu; Patrick M A Sleiman; Hakon Hakonarson
Journal:  J Med Genet       Date:  2018-09-28       Impact factor: 6.318

Review 2.  The debate on treating subclinical hypothyroidism.

Authors:  Eng Loon Tng
Journal:  Singapore Med J       Date:  2016-10       Impact factor: 1.858

3.  Emotional intelligence scores in children and adolescents with subclinical hypothyroidism-correlation with serum serotonin and thyroid-stimulating hormone (TSH) concentrations.

Authors:  George Κ Arianas; Eirini Kostopoulou; Anastasios Ioannidis; Ioannis Dimopoulos; Christos Chiotis; Panagiotis Prezerakos; Bessie E Spiliotis; Andrea Paola Rojas Gil
Journal:  Hormones (Athens)       Date:  2021-11-15       Impact factor: 2.885

Review 4.  Subclinical hypothyroidism in children and adolescents: is it clinically relevant?

Authors:  Aneta Gawlik; Kamila Such; Aleksandra Dejner; Agnieszka Zachurzok; Aleksandra Antosz; Ewa Malecka-Tendera
Journal:  Int J Endocrinol       Date:  2015-03-29       Impact factor: 3.257

5.  Experts' opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta.

Authors:  Aynur Özge; Ishaq Abu-Arafeh; Amy A Gelfand; Peter James Goadsby; Jean Christophe Cuvellier; Massimiliano Valeriani; Alexey Sergeev; Karen Barlow; Derya Uludüz; Osman Özgür Yalın; Noemi Faedda; Richard B Lipton; Alan Rapoport; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2017-11-29       Impact factor: 7.277

Review 6.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

7.  Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism.

Authors:  Andrew T Martin; Susan M Pinney; Changchun Xie; Robert L Herrick; Yun Bai; Jeanette Buckholz; Vincent T Martin
Journal:  Headache       Date:  2016-09-27       Impact factor: 5.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.